🇺🇸 FDA
Patent

US 11318133

Modulators of integrated stress response pathway

granted A61KA61K31/47A61K31/4709

Quick answer

US patent 11318133 (Modulators of integrated stress response pathway) held by PRAXIS BIOTECH LLC expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS BIOTECH LLC
Grant date
Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K31/47, A61K31/4709, A61K31/496, A61K45/06